Treatment of Surgical Site Infections
Suture removal plus incision and drainage is the primary treatment for surgical site infections, with adjunctive systemic antibiotics reserved for cases with significant systemic response or specific high-risk features 1, 2.
Primary Management Approach
The cornerstone of SSI treatment is surgical source control through suture removal and incision/drainage (strong recommendation) 1, 2. This mechanical intervention addresses the fundamental problem—infected material and foreign bodies that perpetuate infection.
When to Add Systemic Antibiotics
Antibiotics are NOT routinely indicated after adequate drainage 1, 2. However, add systemic antimicrobials when ANY of these criteria are present:
- Erythema and induration extending >5 cm from wound edge
- Temperature >38.5°C
- Heart rate >110 beats/minute
- WBC count >12,000/µL
This represents a weak recommendation with low-quality evidence, but the clinical logic is sound—systemic signs indicate infection beyond what drainage alone can address 2.
Antibiotic Selection by Surgical Site
The choice of antimicrobial depends entirely on the anatomic location and contamination risk of the original surgery 1:
Clean Operations (Trunk, Head/Neck, Extremities Away from Axilla/Perineum)
Target Staphylococcus aureus and streptococci:
For MSSA (methicillin-susceptible):
- Cefazolin 0.5-1 g IV every 8 hours (first choice) 1
- Cephalexin 500 mg PO every 6 hours
- Oxacillin or nafcillin 2 g IV every 6 hours
For MRSA risk factors (nasal colonization, prior MRSA infection, recent hospitalization, recent antibiotics):
- Vancomycin 15 mg/kg IV every 12 hours 1, 2
- Linezolid, daptomycin, ceftaroline, or telavancin as alternatives
Operations on Axilla or Perineum
Require coverage for gram-negatives and anaerobes:
Combination regimens:
- Metronidazole 500 mg IV every 8 hours PLUS:
- Ciprofloxacin 400 mg IV every 12 hours (or 750 mg PO every 12 hours), OR
- Levofloxacin 750 mg IV every 24 hours, OR
- Ceftriaxone 1 g IV every 24 hours 1
Operations on GI Tract or Genitourinary Tract
Polymicrobial coverage essential:
Single-drug regimens:
- Piperacillin-tazobactam 3.375 g every 6 hours or 4.5 g every 8 hours IV 1
- Ertapenem 1 g IV every 24 hours
- Meropenem 1 g IV every 8 hours
- Imipenem-cilastatin 500 mg IV every 6 hours
Combination regimens:
- Ceftriaxone 1 g every 24 hours + metronidazole 500 mg every 8 hours IV 1
- Levofloxacin 750 mg IV every 24 hours + metronidazole 500 mg every 8 hours IV
- Ciprofloxacin 400 mg IV every 12 hours + metronidazole 500 mg every 8 hours IV
Critical Timing Considerations
Early postoperative fever (<48 hours) is rarely due to SSI—these infections are almost always Streptococcus pyogenes or Clostridium species if they occur this early 2. Perform Gram stain immediately if purulent drainage appears to rule out these aggressive pathogens, which require penicillin plus clindamycin 1, 2.
Fever after 4 days postoperatively makes SSI more likely and mandates careful wound inspection 2.
Duration of Therapy
A brief course of 5 days is typically sufficient, but extend treatment if infection has not improved within this timeframe 1. The evidence base here is limited, so clinical judgment based on wound appearance and systemic signs should guide duration.
Common Pitfalls to Avoid
- Do not give antibiotics without adequate drainage—this is futile and promotes resistance 1, 2
- Do not assume all early fever is infection—most fever in the first 48 hours is non-infectious 2
- Do not use narrow-spectrum agents for GI/GU tract operations—polymicrobial coverage is mandatory 1
- Do not forget MRSA risk factors—failure to cover MRSA in high-risk patients leads to treatment failure 2
Severe/Necrotizing Infections
If signs of systemic toxicity, necrotizing fasciitis, or gas gangrene are present, immediate surgical consultation is mandatory with broad empiric coverage: vancomycin or linezolid PLUS piperacillin-tazobactam or a carbapenem (or ceftriaxone plus metronidazole) 1. These infections can be polymicrobial or monomicrobial (group A strep, community-acquired MRSA) and carry high mortality without aggressive intervention.